United Kingdom· GB-APID-7503311000001105
Primene 10% solution for infusion 100ml bottles
A medicinal product containing l-leucine, registered in United Kingdom by Baxter Healthcare Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- L-Leucine
- Manufacturer
- Baxter Healthcare Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin05413760278469
- gtin5413760278469
- gtin55413760278464
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
L-leucine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fec0c1b4-8b75-4af8-b9f6-86e24c7d5666 GET /v1/drugs/fec0c1b4-8b75-4af8-b9f6-86e24c7d5666?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "7503311000001105",
"desc": "Primene 10% solution for infusion 100ml bottles (Baxter Healthcare Ltd)",
"form": "Solution for infusion",
"vpid": "7503111000001108",
"source": "dmd",
"vtm_id": null,
"strength": "10 gram",
"substance": null,
"ingredient": "L-Leucine",
"supplier_code": "2063601000001104"
}See everything about l-leucine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.